Where does Abion Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Abion Inc. ranks #16,541 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Abion Inc. hold?

Abion Inc. holds 17 US utility patents granted between 2016 and 2025, spanning 14 technology areas.

What is Abion Inc.'s Innovation Score?

Abion Inc. has an Innovation Score of 35.4 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Abion Inc. focus on?

Abion Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 11 patents, ranking #1,740 of 6,058 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is Abion Inc.'s patent grant rate increasing or decreasing?

Abion Inc.'s recent grant velocity is +120% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Abion Inc.'s patents?

Abion Inc.'s patents average 10.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Abion Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Abion Inc.

USPTO PatentsView assignee record - 17 granted patents across 14 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abion ranks #16,541 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 14 technology areas.

#16,541
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.4/100): 10.8
avg claims per patent: +120%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16541 · Foreign Corporation #16,541 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #16,541/49,997
PHOTO-FINISH 1st Detect
CPC-FOCUS A61P · 14 areas
INNOV-THIN 35.4/100
CLAIMS-PAR 10.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +120% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: 1st Detect Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Abion’s 35.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (28%) Velocity 5.7 pts (16%) Breadth 13.2 pts (37%) Claim depth 6.5 pts (18%)

Qualcomm Incorporated · highest

85
Abion · this assignee

35
3D Lighting… · lowest

7

What this shows Abion's Innovation Score is 35.4/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Abion?

Each dot is one of Abion’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abion’s own 10.8 claims/patent is at or below the 13.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Abion vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Abion's grants concentrate

Abion Inc. is a focused PatentsView assignee: 14 CPC subclasses with 64.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2016. By volume, Abion sits between thyssenkrupp Rasselstein GmbH and Active Tools International (HK) Ltd..

Abion's three-year grant acceleration

Abion Inc. shows 6 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

thyssenkrupp Rass…

18
1st Detect

17
3 Strike

17
3B Medical

17
Able World Intern…

17
Acelon Chemicals…

17
ACK Ventures Hold…

17
Active Tools Inte…

17
Abion ◀

17

What this shows Abion holds 17 patents at rank #16,539, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abion

By rank, the assignees closest to #16,539 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Abion's primary technology class.

Abion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Abion Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	5.9%
2017	2	11.8%
2019	2	11.8%
2020	2	11.8%
2021	3	17.6%
2022	2	11.8%
2023	1	5.9%
2024	3	17.6%
2025partial year	1	5.9%

Which technologies does Abion Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

C07K - Peptides 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

C07D - Heterocyclic Compounds 2

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C07C - Acyclic OR Carbocyclic Compounds 1

Y04S - Systems Integrating Technologies Related TO Power Network Operation, Communication OR Information Technologies FOR Improving THE Electrical Power Generation, Transmission, Distribution, Management OR Usage, i.e. Smart Grids 1

G01H - Measurement OF Mechanical Vibrations OR Ultrasonic, Sonic OR Infrasonic Waves 1

Y02T - Climate Change Mitigation Technologies Related TO Transportation 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Abion Inc.'s patent record in context - here's where to go next.

Abion Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 64.7% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #16,541 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Abion Inc. against thyssenkrupp Rasselstein GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.